Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index

Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes by baseline age and body mass index

Abstract Aims/Introduction Many East Asians with type 2 diabetes are elderly and have a low body mass index (BMI), especially in 'super‐aged' populations, such as Japan. This post‐hoc analysis assessed once‐weekly semaglutide efficacy and safety in Japanese individuals with type 2 diabetes...

Full description

Bibliographic Details
Main Authors: Daisuke Yabe, Yuichiro Yamada, Kohei Kaku, Tomoyuki Nishida, Toshihiro Sato, Yutaka Seino
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Journal of Diabetes Investigation
Subjects:
Body mass index
Diabetes mellitus
type 2
Glucagon‐like peptide‐1
Online Access:https://doi.org/10.1111/jdi.13773

Internet

https://doi.org/10.1111/jdi.13773

Similar Items